North America Cerebrospinal Fluid Management Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cerebrospinal Fluid Management Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cerebrospinal Fluid Management Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Cases of Cerebrospinal Fluid Leak
5.1.2 Developments in CSF Management Products

5.2 Market Opportunities

5.2.1 Increasing Focus on CSF Management in Neurological Diseases

5.3 Future Trends

5.3.1 Development of Cerebrospinal Fluid Shunts

5.4 Impact of Drivers and Restraints

6. North America Cerebrospinal Fluid Management Market Regional Analysis

6.1 North America Cerebrospinal Fluid Management Market Overview

6.2 North America Cerebrospinal Fluid Management Market Revenue 2020-2030 (US$ Million)

6.3 North America Cerebrospinal Fluid Management Market Forecast Analysis

7. North America Cerebrospinal Fluid Management Market Analysis – by Product

7.1 CSF Shunts and CSF Drainage Systems

7.1.1 Overview
7.1.2 CSF Shunts and CSF Drainage Systems: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cerebrospinal Fluid Management Market Analysis – by End User

8.1 Hospitals

8.1.1 Overview
8.1.2 Hospitals: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Clinics

8.2.1 Overview
8.2.2 Clinics: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Ambulatory Surgical Centers

8.3.1 Overview
8.3.2 Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Cerebrospinal Fluid Management Market – North America Analysis

9.1 North America

9.1.1 North America Cerebrospinal Fluid Management Market Breakdown, by Key Country, 2023 and 2030 (%)
9.1.1.1 North America Cerebrospinal Fluid Management Market – Revenue and Forecast Analysis – by Country
9.1.1.1 US: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 US: North America Cerebrospinal Fluid Management Market Breakdown, by Product
9.1.1.1.2 US: North America Cerebrospinal Fluid Management Market Breakdown, by End User

9.1.1.2 Canada: North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Canada: North America Cerebrospinal Fluid Management Market Breakdown, by Product
9.1.1.2.2 Canada: North America Cerebrospinal Fluid Management Market Breakdown, by End User

9.1.1.3 Mexico : North America Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Mexico : North America Cerebrospinal Fluid Management Market Breakdown, by Product
9.1.1.3.2 Mexico : North America Cerebrospinal Fluid Management Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. North America Cerebrospinal Fluid Management Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Argi Group Health Services Ltd Sti

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 B. Braun SE

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 BeckerSmith Medical Inc

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Integra LifeSciences Holdings Corp

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Medtronic Plc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Natus Medical Inc

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Sophysa SA

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Spiegelberg GmbH & Co KG

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights